Skip to content

Stereotaxis STXS Current ratio

Current ratio at other companies

Abbott logo
AbbottABT
1.4×-0.4×
Boston Scientific logo
Boston ScientificBSX
1.9×+0.4×
Medtronic logo
MedtronicMDT
2.1×+0.3×
Stryker logo
StrykerSYK
2.1×+0.5×
ITG
Integer HoldingsITGR
3.8×+0.4×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×

Where this comes from

Calculated from Stereotaxis’s reported figures.

Based on the most recent quarter.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's current ratio?
Stereotaxis (STXS) reported current ratio of 1.6× in Q1 2026.
How has Stereotaxis's current ratio changed year-over-year?
Stereotaxis's current ratio increased by 45.9% year-over-year, from 1.1× to 1.6×.
What is the long-term trend for Stereotaxis's current ratio?
Over 5 years (2020 to 2025), Stereotaxis's current ratio has grown at a -17.2% compound annual growth rate (CAGR), from 3.9× to 1.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.